Win-Win, a gamified donation platform, is moving to Houston this summer. Photo via Facebook

It's a homecoming of sorts for Mike T. Brown, a professional athlete turned entrepreneur, who is moving his Silicon Valley-founded startup to his hometown of Houston. Win-Win is a tech-enabled platform where fans can donate to their favorite athletes' causes through a gamified donation platform.

The company launched in 2016 and since raised $1.2 million in funding. Win-Win is ready to scale, according to a press release, and launch full-scale during the 2019 NFL season. Currently, the company is accepting investors on a crowdfunding site.

Brown will move his team into The Cannon this summer and enter The Cannon's Venture Studio.

"I couldn't be more excited about returning to Houston to become a part of the city's tech revolution," says Brown in the release. "After visiting The Cannon, I immediately felt the energy and have witnessed their commitment to pushing Houston's tech startup movement. I can't wait to get fully plugged into the city's ecosystem, to start hiring local talent and raising money from local investors."

Brown spent four years in the NFL, and was at one point a linebacker for the Indianapolis Colts. He hung up his helmet in 2013, taught himself to code, and moved to Silicon Valley. He worked as a mid-market growth lead for a $32 million venture-backed startup called Kiip. Growing up in Houston, Brown attended Alief Taylor High School before playing football at Duke University, getting a degree in public policy.

Win-Win is moving to the city at a time when sports startups are thriving, says Lawson Gow, founder and CEO of The Cannon. Gow is the son of InnovationMap's parent company's CEO. The Cannon is also home to sports tech startup sEATz.

"Houston has long needed better entrepreneurial resources to stop our startups from leaving for greener pastures, and we are excited to be part of the local entrepreneurial growth over the last couple of years, helping to provide a landing spot for a young, growing company like Win-Win," says Gow in the release. "On top of that, Houston is extremely well-positioned to be the home for sports-tech startups, and Mike moving back can be a great catalyst towards continuing to establish our city as a sports-tech hub."

Win-Win is joining fellow sports tech startup sEATz at The Cannon.Courtesy of The Cannon

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.